During the past decade, St George Dermatology and Skin Cancer Centre conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St George Dermatology and Skin Cancer Centre" #1 sponsor was "Peplin" with 5 trials, followed by "Pfizer" with 5 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Dermira, Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St George Dermatology and Skin Cancer Centre" #1 collaborator was "Celtaxsys Aus Pty Limited" with 1 trials as a collaborator, "Clinical Network Services (CNS) Pty Ltd" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "TKL Research, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "St George Dermatology and Skin Cancer Centre" are "Alopecia Areata" (5 trials), "Acne Vulgaris" (3 trials), "Psoriasis" (3 trials), "Actinic Keratosis" (2 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "St George Dermatology and Skin Cancer Centre" in a lesser frequency.

Most popular intervention types in "St George Dermatology and Skin Cancer Centre" are "Drug" (21 trials), "Biological" (2 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Abrocitinib 200 mg" (2 trials), "BMS-986165" (2 trials), "Olumacostat Glasaretil Gel, 5.0%" (2 trials) and "PEP005" (2 trials). Other intervention names were less common.

The vast majority of trials in "St George Dermatology and Skin Cancer Centre" are 21 trials for "All" genders.

Currently, there are NaN active trials in "St George Dermatology and Skin Cancer Centre". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in St George Dermatology and Skin Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St George Dermatology and Skin Cancer Centre, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".